Gastroenterology @Point of Care Podcasts

In this episode, our faculty, Arun Sanyal, MD and Mary Rinella, MD, discuss managing MASH in primary care. Learn how to stratify risk using noninvasive testing, initiate lifestyle and pharmacologic interventions, and recognize when to refer. Equip yourself with tools to improve outcomes before cirrhosis and complications arise. Visit https://suitehome.atpointofcare.com/library/2711.02/page/0?subdomain=mash to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode, our faculty, Arun Sanyal, MD and Mary Rinella, MD, discuss screening and early intervention of MASH, a silent but progressive liver disease. Dr. Sanyal and Dr. Rinella highlight the critical role of primary care physicians in early detection, risk assessment using noninvasive tests, and timely referral—empowering clinicians to intervene before cirrhosis develops. Visit https://suitehome.atpointofcare.com/library/2711.01/page/0?subdomain=mash to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode, Recognizing and Managing SBS: Helping Patients Achieve Enteral Autonomy, Dr. John DiBaise and Carol Rees Parrish discuss how clinicians can help patients manage their disease and improve their quality of life, and importantly, how clinicians can help patients reduce the need for parenteral support.   Visit https://suitehome.atpointofcare.com/library/2673.12/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

In this episode, Intestinal Adaptation in SBS: What’s New on GLP-2?, Dr. John DiBaise and Dr. Andrew Ukleja discuss short bowel syndrome and the role that GLP-2 analogs can play in the management of this disease. What do clinicians need to know in order to feel comfortable with their use?   Visit https://suitehome.atpointofcare.com/library/2673.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Chronic hepatitis B virus (HBV) is a long-term disease that requires monitoring to determine when to start therapy, evaluate ongoing disease activity, and assess on-treatment disease suppression. Drs. Paul Kwo and Mindie Nguyen discuss guideline approaches to starting and monitoring HBV treatment, how to mitigate complications, and barriers and disparities in HBV care and potential solutions for clinicians to provide optimal care for their patients. Visit https://suitehome.atpointofcare.com/library/2663.03/page/0?subdomain=hepatitis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

For patients with chronic hepatitis B virus (HBV), many new therapies are in development with the objective of providing improved functional cure rates. We are also learning that combining therapies with different mechanisms of action may provide functional cure benefits that exceed those seen with monotherapy. Drs. Paul Kwo and Mindie Nguyen discuss new treatments in development for the treatment of chronic hepatitis B and the ongoing pivotal trials for these new therapies. Visit https://suitehome.atpointofcare.com/library/2663.02/page/0?subdomain=hepatitis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Hepatitis B presents a huge health burden, affecting an estimated 2 million people in the US alone. In this episode, Dr. Paul Kwo and Dr. Mindie Nguyen discuss the disease burden, guideline-directed best practices for the screening, evaluation, and management of the disease, and therapy targets and functional cure.  Visit https://suitehome.atpointofcare.com/library/2663.01/page/0?subdomain=hepatitis to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Dr. Evan Dellon and Dr. Emily McGowan discuss the features measured by the I-SEE clinical index and its role in evaluating EoE severity, as well as evidence behind the ongoing validation of this tool and implications for future use.  Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

Without a standardized approach to severity assessment, eosinophilic esophagitis (EoE) is challenging to evaluate and monitor. To address this, the Index of Severity in EoE (I-SEE) was developed by leading experts in collaboration with the American Gastroenterological Association (AGA) and is designed to be easily used in routine practice. In this episode, Drs. Evan Dellon and Nirmala Gonsalves discuss the roles of different assessment tools in clinical practice, how they traditionally evaluate disease severity, and why the EoE community saw a need for something like the I-SEE Clinical Index.  Visit https://suiteweb.atpointofcare.com/#library/eoe/2658.01/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.